SUBSCRIBE
SUBSCRIBE

Merck & Co.

  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
213 E Grand Ave, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA
NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Investors Disappointed as Merck & Co. Sales of Januvia and Remicade Fall Short
May 5, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Federal Judge Reopens Gilead Case Amid Allegations Former Merck & Co. Scientist Lied
April 29, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Gilead Ordered to Pay Merck & Co. $200 Million in Damages Over Hep C Patent Dispute
March 25, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
More Bad Luck for Gilead as Merck & Co. Wins Victory in Hep C Patent Dispute
March 23, 2016
 · 
3 min read
Biotech Bay
The 8 Best Pharmaceutical Companies to Work for
Looking for the best pharmaceutical companies to work for? Here’s the list of the top 8 pharma companies that are hiring right now. So, let’s check the list.
March 16, 2016
 · 
8 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Sanofi and Merck & Co. to Dismantle Joint Vaccines Venture After 22 Years
March 8, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Gilead, Merck & Co. Duke It Out Over Hep C $1,000-Pill Royalties
March 8, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
FDA Spurns Merck & Co.'s Cardiovascular Claims for Zetia, Vytorin
February 16, 2016
 · 
2 min read
Job Trends
Merck & Co. to Create 200 New Jobs Across Three Irish Counties
February 15, 2016
 · 
1 min read
Load More
JOBS
IN THE PRESS
Business
IO Biotech enters clinical collaboration with MSD evaluating IO102 in combination with KEYTRUDA® (pembrolizumab) in first-line treatment of patients with metastatic non-small cell lung cancer
March 12, 2018
 · 
1 min read
Business
Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)
March 7, 2018
 · 
18 min read
Pharm Country
Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
March 1, 2018
 · 
7 min read
Pharm Country
LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion in Platinum-Sensitive Relapsed Ovarian Cancer
February 23, 2018
 · 
16 min read
Drug Development
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
February 22, 2018
 · 
9 min read
Deals
Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline
February 21, 2018
 · 
11 min read
BioCapital
APhA Celebrates Pharmacists’ Contributions to Increasing U.S. Immunization Rates and Improving Health
February 20, 2018
 · 
2 min read
Drug Development
Selumetinib Granted Orphan Drug Designation by the U.S. FDA for Neurofibromatosis Type 1
February 15, 2018
 · 
7 min read
Business
Parkinson’s Institute and Clinical Center Collaborates with Merck to Evaluate LRRK2 Kinase Inhibition in Preclinical Model of Parkinson’s Disease
February 5, 2018
 · 
2 min read
Business
Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results
February 2, 2018
 · 
39 min read
Load More